Teva anuncia resultados provisionales prometedores de su estudio PEARL sobre el impacto de AJOVY® (fremanezumab) | Business Wire
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Teva Pharmaceutical Industries names a new CEO
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva's two new digital inhalers complete Digihaler product line | MobiHealthNews
Teva llega a un acuerdo por $117 millones en demandas relacionadas con los opioides en Florida
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva slide could draw vultures but it won't be easy prey | The Times of Israel
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva lied about opioid role, New York says | Reuters
In opioid case, NY wants to probe Teva's control of Teva USA
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet